Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1981 Mar;31(3):1223–1231. doi: 10.1128/iai.31.3.1223-1231.1981

Role of antibody to leukocytosis-promoting factor hemagglutinin and to filamentous hemagglutinin in immunity to pertussis.

Y Sato, K Izumiya, H Sato, J L Cowell, C R Manclark
PMCID: PMC351446  PMID: 6262248

Abstract

Gamma globulins were obtained from rabbits hyperimmunized with the filamentous hemagglutinin (FHA) or the leukocytosis-promoting factor hemagglutinin (LPF.HA) of Bordetella pertussis. Double immunodiffusion analyses showed the antibodies to be highly specific for the homologous antigen. Intraperitoneal injection of anti-FHA or anti-LPF.HA into 10-day-old ICR mice 30 min before aerosol challenge with B. pertussis protected the mice from disease as evidenced by survival and a normal rate of gain in body weight. Both anti-LPF.HA and anti-FHA enhanced the clearance of B. pertussis from the lung and prevented leukocytosis which normally occurs after aerosol infection of mice with B. pertussis. Anti-LPF.HA, but not anti-FHA, neutralized the leukocytosis-promoting and histamine-sensitizing activities of LPF.HA when incubated with the purified protein in vitro. Anti-FHA, but not anti-LPF.HA, prevented the attachment of B. pertussis to mammalian cells (HeLa and Vero) in culture.

Full text

PDF

Images in this article

1226Image
on p.1226
1228Image
on p.1228
1229Image
on p.1229

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANDERSEN E. K. Some observations made during experiments on mice inoculated with H. pertussis. Acta Pathol Microbiol Scand. 1952;31(4):546–560. doi: 10.1111/j.1699-0463.1952.tb00222.x. [DOI] [PubMed] [Google Scholar]
  2. Arai H., Munoz J. J. Fimbrial hemagglutinin in stationary and shake cultures of Bordetella pertussis. Infect Immun. 1979 Aug;25(2):764–767. doi: 10.1128/iai.25.2.764-767.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Arai H., Sato Y. Separation and characterization of two distinct hemagglutinins contained in purified leukocytosis-promoting factor from Bordetella pertussis. Biochim Biophys Acta. 1976 Oct 22;444(3):765–782. doi: 10.1016/0304-4165(76)90323-8. [DOI] [PubMed] [Google Scholar]
  4. FISHER S., WARBURTON M. F., WETTENHALL H. N. B., WILLIAMS S. W. The haemagglutinin of Haemophilus pertussis. IV. Reactions and antibody response in babies and children following the administration of haemagglutinin absorbed on aluminum phosphate. Aust J Exp Biol Med Sci. 1951 Nov;29(6):425–432. [PubMed] [Google Scholar]
  5. Irons L. I., MacLennan A. P. Isolation of the lymphocytosis promoting factor-haemagglutinin of Bordetella pertussis by affinity chromatography. Biochim Biophys Acta. 1979 Sep 29;580(1):175–185. doi: 10.1016/0005-2795(79)90208-3. [DOI] [PubMed] [Google Scholar]
  6. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  7. MASRY F. L. G. Production, extraction and purification of haemagglutinin of Haemophilus pertussis. J Gen Microbiol. 1952 Nov;7(3-4):201–210. doi: 10.1099/00221287-7-3-4-201. [DOI] [PubMed] [Google Scholar]
  8. Matsuyama T. Resistance of Bordetella pertussis phase I to mucociliary clearance by rabbit tracheal mucous membrane. J Infect Dis. 1977 Nov;136(5):609–616. doi: 10.1093/infdis/136.5.609. [DOI] [PubMed] [Google Scholar]
  9. Morse S. I., Morse J. H. Isolation and properties of the leukocytosis- and lymphocytosis-promoting factor of Bordetella pertussis. J Exp Med. 1976 Jun 1;143(6):1483–1502. doi: 10.1084/jem.143.6.1483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. PILLEMER L. Adsorption of protective antigen of Hemophilus pertussis on human red cell stromata. Proc Soc Exp Biol Med. 1950 Dec;75(3):704–705. doi: 10.3181/00379727-75-18311. [DOI] [PubMed] [Google Scholar]
  11. PRESTON N. W., EVANS P. Type-specific immunity against intracerebral pertussis infection in mice. Nature. 1963 Feb 2;197:508–509. doi: 10.1038/197508a0. [DOI] [PubMed] [Google Scholar]
  12. Preston N. W., Stanbridge T. N. Mouse or man? Which are pertussis vaccines to protect? J Hyg (Lond) 1976 Apr;76(2):249–256. doi: 10.1017/s0022172400055145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. STANDFAST A. F. Some factors influencing the virulence for mice of Bordetella pertussis by the intracerebral route. Immunology. 1958 Apr;1(2):123–134. [PMC free article] [PubMed] [Google Scholar]
  14. Sato Y., Arai H., Suzuki K. Leukocytosis-promoting factor of Bordetella pertussis. 3. Its identity with protective antigen. Infect Immun. 1974 May;9(5):801–810. doi: 10.1128/iai.9.5.801-810.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Sato Y., Izumiya K., Sato H., Cowell J. L., Manclark C. R. Aerosol infection of mice with Bordetella pertussis. Infect Immun. 1980 Jul;29(1):261–266. doi: 10.1128/iai.29.1.261-266.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. THIELE E. H. Studies on the hemagglutinin of Hemophilus pertussis. J Immunol. 1950 Dec;65(6):627–632. [PubMed] [Google Scholar]
  17. Utsumi S., Sonoda S., Imagawa T., Kanoh M. Polymorphonuclear leukocyte-inhibitory factor of Bordetella pertussis. I. Extraction and partial purification of phagocytosis- and chemotaxis-inhibitory activities. Biken J. 1978 Dec;21(4):121–135. [PubMed] [Google Scholar]
  18. Weber K., Pringle J. R., Osborn M. Measurement of molecular weights by electrophoresis on SDS-acrylamide gel. Methods Enzymol. 1972;26:3–27. doi: 10.1016/s0076-6879(72)26003-7. [DOI] [PubMed] [Google Scholar]
  19. Yajima M., Hosoda K., Kanbayashi Y., Nakamura T., Takahashi I., Ui M. Biological properties of islets-activating protein (IAP) purified from the culture medium of Bordetella pertussis. J Biochem. 1978 Jan;83(1):305–312. doi: 10.1093/oxfordjournals.jbchem.a131905. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES